Use Of Plasma Cell Immunophenotype As Prognostic Markers In Patients With Systemic AL Amyloidosis

被引：4
|
作者：
Sachchithanantham, Sajitha
Baginska, Anna
Rowczenio, Dorota
Mahmood, Shameem
Sayed, Rabya
Patel, Ketna
Lane, Thirusha
Rannigan, Lisa
Foard, Darren
Whelan, Carol
Lachmann, Helen
Gillmore, Julian D.
Hawkins, Philip N.
Wechalekar, Ashutosh
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3120.3120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3120
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Hemostasis disorders in patients with systemic AL-amyloidosis
    Rekhtina, Irina G.
    Khyshova, Victoria A.
    Zozulya, Nadezhda I.
    Dvirnyk, Valentina N.
    Mendeleyeva, Larisa P.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (09) : 746 - 750
  • [22] Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis
    Chee, Cheng E.
    Rajkumar, S. Vincent
    Gertz, Morie Abraham A.
    Lacy, Martha
    Zeldenrust, Steven
    Kumar, Shaji
    Hayman, Suzanne R.
    Buadi, Francis
    Russell, Stephen
    Kyle, Robert
    Greipp, Philip R.
    Dispenzieri, Angela
    BLOOD, 2010, 116 (21) : 790 - 790
  • [23] Prognostic values of novel biomarkers in patients with AL amyloidosis
    Kim, Darae
    Lee, GaYeon
    Choi, Jin-Oh
    Kim, Kihyun
    Kim, SeokJin
    Ju, Eun-Seon
    Jeon, Eun-Seok
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [24] Possible use of lymphoid CD subsets as prognostic markers for Plasma Cell Dyscrasias
    Greco, C
    Alvino, S
    Marcucci, M
    Mosiello, A
    Mattei, F
    Valente, F
    Francavilla, V
    Arista, C
    Cianciulli, AM
    Gandolfo, GM
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 1997, 41 : 21 - 22
  • [25] Autologous Hematopoietic Stem Cell Transplant (aHSCT) is a Safe and Reasonable Treatment in Patients with Primary Systemic Amyloidosis (AL amyloidosis)
    Pandit, Akshata
    Wei, Lai
    Elder, Patrick
    Falk, William
    Sell, Megan
    Hofmeister, Craig C.
    Benson, Don M.
    Penza, Sam
    Andritsos, Leslie A.
    Klisovic, Rebecca
    Vasu, Sumithira
    Blum, William
    Devine, Steven M.
    Jaglowski, Samantha
    Efebera, Yvonne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S186 - S186
  • [26] Combined use of two monoclonal antibodies in patients with systemic AL amyloidosis and cardiac involvement.
    Godara, Amandeep
    Siddiqui, Nauman Saleem
    Lee, Lisa
    Toskic, Denis
    Fogaren, Teresa
    Varga, Cindy
    Comenzo, Ray
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Systemic AL Amyloidosis From Plasma Cell Neoplasm in Younger Population Presenting With Gastrointestinal Symptoms Primarily
    Salehani, Atousa
    Ghias, Saif
    Takher, Jasprit
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1758 - S1758
  • [28] Deferred autologous stem cell transplantation in systemic AL amyloidosis
    Manwani, Richa
    Hegenbart, Ute
    Mahmood, Shameem
    Sachchithanantham, Sajitha
    Kyriakou, Charalampia
    Yong, Kwee
    Popat, Rakesh
    Rabin, Neil
    Whelan, Carol
    Dittrich, Tobias
    Kimmich, Christoph
    Hawkins, Philip
    Schoenland, Stefan
    Wechalekar, Ashutosh
    BLOOD CANCER JOURNAL, 2018, 8
  • [29] Deferred autologous stem cell transplantation in systemic AL amyloidosis
    Richa Manwani
    Ute Hegenbart
    Shameem Mahmood
    Sajitha Sachchithanantham
    Charalampia Kyriakou
    Kwee Yong
    Rakesh Popat
    Neil Rabin
    Carol Whelan
    Tobias Dittrich
    Christoph Kimmich
    Philip Hawkins
    Stefan Schönland
    Ashutosh Wechalekar
    Blood Cancer Journal, 8
  • [30] Analysis of plasma cell clonality in localized AL amyloidosis
    Setoguchi, M
    Hoshii, Y
    Kawano, H
    Ishihara, T
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2000, 7 (01): : 41 - 45
12345